Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Hausegger, KA; Portugaller, HR.
Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.
Eur Radiol. 2006; 16(9):2016-2030
Doi: 10.1007/s00330-005-0136-7
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Portugaller Rupert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In this review the technique, indication for and complications of percutaneous nephrostomy (PCN) and antegrade ureter stent insertion are described. In the majority of the cases PCN is performed to relieve urinary obstruction, which can be of benign or malignant nature. Another indication for PCN is for treatment of urinary fistulas. PCN can be performed under ultrasound and/or fluoroscopic guidance, with a success rate of more than 90%. The complication rate is approximately 10% for major and minor complications together and 4-5% for major complications only. Percutaneous antegrade double-J stent insertion usually is performed if retrograde ureter stenting has not been successful. However, especially in malignant obstructions, the success rate for antegrade stenting is higher than for retrograde transvesical double-J stent insertion. In the case of severe infection and bleeding after PCN JJ-stent insertion may be contraindicated so long as there is no sufficient concomitant drainage via a PCN . Lower urinary tract dysfunction should be excluded before stent placement. The complication rate is 2-4%. Consequent stent surveillance with regular stent exchange is mandatory.
- Find related publications in this database (using NLM MeSH Indexing)
-
Catheters, Indwelling -
-
Humans -
-
Nephrostomy, Percutaneous - adverse effects
-
Stents - adverse effects
-
Urologic Diseases - surgery
- Find related publications in this database (Keywords)
-
kidney
-
interventional procedures
-
percutaneous nephrostomy
-
urinary tract obstruction
-
ureter
-
stents